AMD kicks of CES 2025 with a bang: its Ryzen AI Max processor combines discrete-level graphics with powerful AI, all ...

In the early days of the artificial intelligence (AI) infrastructure build-out, graphic processing units (GPUs) have been the ...

Read here for an update on AMD's product roadmap, AI hardware challenges, valuation, and market sentiment for potential ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

AMD announced its Ryzen AI Max processors at CES, ushering in a new series of AMD -based AI PCs and laptops. The chipmaker ...

Intel's Core Ultra 9 285H has demonstrated a performance edge over AMD's Ryzen AI 9 365 in user reviews, particularly noted in synthetics testing. Based on the provided reviews, the 9 285H seems to ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

At the top of the lineup is the Ryzen AI Max+ 395, featuring 16 CPU cores, 40 GPU cores, and support for up to 128GB of ...

AMD's Ryzen AI Max chips came as a huge surprise at CES 2025. They're basically super-powered versions of the company's Ryzen ...

In an internal test, AMD used the Ryzen AI Max+ 395 to run a version of the Llama 70B large language model. The company says ...